Rational Discovery of Molecular Glues and Proximity-Based Therapeutics Across Diverse Disease Areas

• Demonstrating how rational discovery approaches are enabling the identification of molecular glues and proximity-based therapeutics for targets and indications beyond oncology
• Exploring modality-agnostic strategies spanning molecular glues, PROTACs, and antibody-conjugated degraders to unlock new opportunities across autoimmune and neurological diseases
• Sharing lessons from advancing non-oncology degradation programs to accelerate the translation of induced proximity therapeutics into diverse disease areas

Speakers:

Emanuela Cuomo

Executive Director, Global Head of Discovery Pharmacology

Merck KGaA